PI
VOR icon

Putnam Investments’s Vor Biopharma VOR Stock Holding History

Putnam Investments’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,922
Closed -$3.74M – 1203
2021
Q3 		$3.74M Sell
11,922
-15,578
-57% -$4.63M 0.01% 618
2021
Q2 		$10.3M Hold
27,500
– – 0.02% 363
2021
Q1 		$23.7M Buy
+27,500
New +$23.3M 0.04% 236

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Putnam Investments's VOR Position: Q4 2021 in Review

Putnam Investments sold out of Vor Biopharma (VOR) in Q4 2021, closing a stake of 11,922 shares — an estimated $3.74M sold.

Putnam Investments first reported a position in VOR in Q1 2021 and held it in 3 quarters. The position peaked at $23.7M in Q1 2021. 61 funds tracked by Wall St. Rank hold VOR as of Q4 2021.

  • Putnam Investments reported no remaining Vor Biopharma position as of Q4 2021 after selling out during the quarter.
  • Putnam Investments sold 11,922 Vor Biopharma shares in Q4 2021, an estimated $3.74M.
  • Putnam Investments first reported a position in Vor Biopharma in Q1 2021 and held it in 3 quarters.
  • Putnam Investments's Vor Biopharma position peaked at $23.7M in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Vor Biopharma as of Q4 2021.

Based on Putnam Investments's 13F filing for Q4 2021, filed 14 Feb 2022.